Study time points | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Enrollment | Allocation | Post-allocationa | Closeout | ||||||||
Participants timeline | -t1 In trauma center | 0 | t1 S1 | t2 S2 | t3 S3 | t4 S4 | t5 S5 6 weeks | t6 S6 | t7 S7 | t8 S8 | t9 12 weeks |
Enrollment: | |||||||||||
Eligibility screen/Informed consent | √ | ||||||||||
Screening - risk factors for chronic consumption of opioids | |||||||||||
- Sociodemographic questionnaire | √ | ||||||||||
- ISS | √ | ||||||||||
- ASSIST | √ | ||||||||||
- HADS | √ | ||||||||||
- PCS | √ | ||||||||||
- PSEQ | √ | ||||||||||
Allocation of participants | √ | ||||||||||
Intervention encounters: | |||||||||||
Control group | √ | ||||||||||
Intervention group | √ | √ | √ | √ | √ | √ | √ | √ | |||
Assessments: | |||||||||||
- Intervention feasibility | √ | √ | √ | √ | √ | √ | √ | √ | |||
- Research methods feasibility | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ |
- Acceptability | √ | ||||||||||
- MED/day, non-opioid analgesic(s) intake, BPI | √ | √ | √ |